1u2y

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
A new approach for the discovery and subsequent structural elucidation of, oligosaccharide-based inhibitors of alpha-amylases based upon, autoglucosylation of known alpha-glucosidase inhibitors is presented. This, concept, highly analogous to what is hypothesized to occur with acarbose, is demonstrated with the known alpha-glucosidase inhibitor, d-gluconohydroximino-1,5-lactam. This was transformed from an inhibitor of, human pancreatic alpha-amylase with a K(i) value of 18 mm to a, trisaccharide analogue with a K(i) value of 25 mum. The three-dimensional, structure of this complex was determined by x-ray crystallography and, represents the first such structure determined with this class of, inhibitors in any alpha-glycosidase. This approach to the discovery and, structural analysis of amylase inhibitors should be generally applicable, to other endoglucosidases and readily adaptable to a high throughput, format.
+
A new approach for the discovery and subsequent structural elucidation of oligosaccharide-based inhibitors of alpha-amylases based upon autoglucosylation of known alpha-glucosidase inhibitors is presented. This concept, highly analogous to what is hypothesized to occur with acarbose, is demonstrated with the known alpha-glucosidase inhibitor, d-gluconohydroximino-1,5-lactam. This was transformed from an inhibitor of human pancreatic alpha-amylase with a K(i) value of 18 mm to a trisaccharide analogue with a K(i) value of 25 mum. The three-dimensional structure of this complex was determined by x-ray crystallography and represents the first such structure determined with this class of inhibitors in any alpha-glycosidase. This approach to the discovery and structural analysis of amylase inhibitors should be generally applicable to other endoglucosidases and readily adaptable to a high throughput format.
==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Begum, A.]]
[[Category: Begum, A.]]
-
[[Category: Brayer, G.D.]]
+
[[Category: Brayer, G D.]]
[[Category: Damager, I.]]
[[Category: Damager, I.]]
[[Category: Li, C.]]
[[Category: Li, C.]]
[[Category: Numao, S.]]
[[Category: Numao, S.]]
-
[[Category: Overall, C.M.]]
+
[[Category: Overall, C M.]]
-
[[Category: Withers, S.G.]]
+
[[Category: Withers, S G.]]
-
[[Category: Wrodnigg, T.M.]]
+
[[Category: Wrodnigg, T M.]]
[[Category: CA]]
[[Category: CA]]
[[Category: CL]]
[[Category: CL]]
Line 33: Line 33:
[[Category: inhibitor]]
[[Category: inhibitor]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:59:06 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:20:20 2008''

Revision as of 13:20, 21 February 2008


1u2y, resolution 1.95Å

Drag the structure with the mouse to rotate

In situ extension as an approach for identifying novel alpha-amylase inhibitors, structure containing D-gluconhydroximo-1,5-lactam

Overview

A new approach for the discovery and subsequent structural elucidation of oligosaccharide-based inhibitors of alpha-amylases based upon autoglucosylation of known alpha-glucosidase inhibitors is presented. This concept, highly analogous to what is hypothesized to occur with acarbose, is demonstrated with the known alpha-glucosidase inhibitor, d-gluconohydroximino-1,5-lactam. This was transformed from an inhibitor of human pancreatic alpha-amylase with a K(i) value of 18 mm to a trisaccharide analogue with a K(i) value of 25 mum. The three-dimensional structure of this complex was determined by x-ray crystallography and represents the first such structure determined with this class of inhibitors in any alpha-glycosidase. This approach to the discovery and structural analysis of amylase inhibitors should be generally applicable to other endoglucosidases and readily adaptable to a high throughput format.

About this Structure

1U2Y is a Single protein structure of sequence from Homo sapiens with , , and as ligands. Active as Alpha-amylase, with EC number 3.2.1.1 Full crystallographic information is available from OCA.

Reference

In situ extension as an approach for identifying novel alpha-amylase inhibitors., Numao S, Damager I, Li C, Wrodnigg TM, Begum A, Overall CM, Brayer GD, Withers SG, J Biol Chem. 2004 Nov 12;279(46):48282-91. Epub 2004 Aug 10. PMID:15304511

Page seeded by OCA on Thu Feb 21 15:20:20 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools